Lambart, I.; Flender, D.; Liu, D.; Hong Hoang, J.; Hesse, M.; Campillo-Davo, D.; Lion, E.; Van Audenaerde, J.; Schiller, S.; Simon, J.;
et al. Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine Modification. Pharmaceutics 2026, 18, 403.
https://doi.org/10.3390/pharmaceutics18040403
AMA Style
Lambart I, Flender D, Liu D, Hong Hoang J, Hesse M, Campillo-Davo D, Lion E, Van Audenaerde J, Schiller S, Simon J,
et al. Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine Modification. Pharmaceutics. 2026; 18(4):403.
https://doi.org/10.3390/pharmaceutics18040403
Chicago/Turabian Style
Lambart, Izabella, Daniel Flender, Dana Liu, Jenny Hong Hoang, Max Hesse, Diana Campillo-Davo, Eva Lion, Jonas Van Audenaerde, Stefan Schiller, Johanna Simon,
and et al. 2026. "Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine Modification" Pharmaceutics 18, no. 4: 403.
https://doi.org/10.3390/pharmaceutics18040403
APA Style
Lambart, I., Flender, D., Liu, D., Hong Hoang, J., Hesse, M., Campillo-Davo, D., Lion, E., Van Audenaerde, J., Schiller, S., Simon, J., Geissler, S., Smits, E., Mäder, K., & Zaryouh, H.
(2026). Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine Modification. Pharmaceutics, 18(4), 403.
https://doi.org/10.3390/pharmaceutics18040403
